Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
99.73
-4.25 (-4.09%)
At close: Jan 16, 2026, 4:00 PM EST
97.74
-1.99 (-2.00%)
After-hours: Jan 16, 2026, 5:27 PM EST
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.18 billion as of January 16, 2026. Its market cap has increased by 776.65% in one year.
Market Cap
1.18B
Enterprise Value
1.13B
1-Year Change
776.65%
Ranking
Category
Stock Price
$99.73
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.18B, an increase of 719.93%. That is a compound annual growth rate of 595.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.18B | -4.72% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 934.67B |
| Johnson & Johnson | 528.72B |
| AbbVie | 380.80B |
| UnitedHealth Group | 302.26B |
| AstraZeneca | 291.28B |
| Novartis AG | 273.64B |
| Merck & Co. | 270.94B |
| Novo Nordisk | 252.12B |